pxl.store / Shutterstock.com (The Royal Courts of Justice, where the English High Court is based.)

1 June 2015

English court grants Warner’s appeal in Lyrica second medical use case

The English Court of Appeal has said pharmaceutical company Warner-Lambert has a viable argument that Actavis indirectly infringed a second medical use patent covering Warner’s drug Lyrica (pregabalin).

Already registered?

For multi-user price options, or to check if your company has an existing subscription that we can add you to for FREE, please email Adrian Tapping at atapping@newtonmedia.co.uk

More on this story

Biotech

Tempus AI bid to derail DNA patent case hits snag

31 August 2026 Efforts to shut down an eight-patent dispute over cancer-detection technology have run into a hurdle in a Delaware federal court.

Pharma

Teva faces scrutiny over efforts to curb generic competition

27 August 2026 Turkish regulators are investigating the drugmaker over its efforts to protect its drug from generic rivals—conduct that may sound familiar to European competition watchers.

Regulation & Industry

FDA targets faster generic approvals in drive to slash drug prices

27 August 2026 Dozens of new and revised guidances could make it faster and less costly to bring generics to market, as the US ramps up pressure on drug prices.

More features

Tempus AI bid to derail DNA patent case hits snag

Top law firms and individuals recognised in WIPR’s UK Patent Rankings 2026

Teva faces scrutiny over efforts to curb generic competition

FDA targets faster generic approvals in drive to slash drug prices

China-origin biotech assets and the hidden question of IP ownership

Paul, Weiss finds appellate ‘star’ to lead Supreme Court practice

The buyers' wishlist: What makes a life sciences deal stack up?

UK appoints ex-engineer as new intellectual property Minister

English court grants Warner’s appeal in Lyrica second medical use case

More on this story

Editor's picks

Editor's picks

More features